Home › Treatment Resistant Depression

Treatment Resistant Depression

Treatment-resistant depression is generally defined as the continuation of depression symptoms despite treatment with at least one medication. This study evaluates the effectiveness and safety of an investigational medication or placebo added to an antidepressant.
 

You may qualify for this study if you:

  • have been diagnosed with Major Depressive Disorder (MDD)
  • have been experiencing symptoms of depression for at least the past 2 months.
  • are still at least partially depressed despite treatment with at least one medication.
  • are between 18 and 65 years of age.

All office visits, study related medical and psychiatric evaluations, and study medications will be provided to participants at no cost. Participants will be reimbursed for time and travel expenses.

For more information call 410-602-1440

  

Studies Seeking Volunteers

Geriatric Anxiety
PharmaSite Research is currently offering a clinical research study of a investigational medication for Generalized Anxiety Disorder in elderly patients.
Children and Adolescents with Anxiety
PharmaSite Research is currently offering a clinical research study for Generalized Anxiety Disorder in Children and Adolescents.
Bipolar Disorder / Manic Depression
PharmaSite Research is currently offering a clinical research study for depression associated with Bipolar 1 disorder.
Depression
PharmaSite Research is currently offering a clinical research study of a novel investigational medication for depression in adults. Major Depression is generally defined as experience of multiple symptoms of depression for at least 2 weeks.
Depression in Children and Adolescents
PharmaSite Research is currently offering a clinical research study of an investigational medication for depression in children and adolescents.
Treatment Resistant Depression
Treatment-resistant depression is generally defined as the continuation of depression symptoms despite treatment with at least one medication. This study evaluates the effectiveness and safety of an investigational medication or placebo added to an antidepressant.

More Studies...